These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8903411)

  • 1. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis.
    Burr AW; Hillan KJ; McLaughlin KE; Ferrier R; Chapman C; Mathew J; Burt AD
    Hepatology; 1996 Nov; 24(5):1282-7. PubMed ID: 8903411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
    Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
    J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.
    Bell A; Chen Q; DeFrances MC; Michalopoulos GK; Zarnegar R
    Oncogene; 1999 Jan; 18(4):887-95. PubMed ID: 10023664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet.
    Nakanishi C; Moriuchi A; Ido A; Numata M; Kim ID; Kusumoto K; Hasuike S; Abe H; Nagata K; Akiyama Y; Uto H; Kataoka H; Tsubouchi H
    Oncol Rep; 2006 Jul; 16(1):25-31. PubMed ID: 16786119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
    J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of hepatocyte growth factor (HGF) in LEC rats at various phases of hepatitis and hepatoma].
    Nakayama N
    Hokkaido Igaku Zasshi; 1995 Jul; 70(4):609-21. PubMed ID: 7590606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis.
    Leng T; Liu N; Dai Y; Yu Y; Zhang C; Du R; Chen X
    J Proteome Res; 2010 Dec; 9(12):6207-19. PubMed ID: 20919743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.